JP2021525220A5 - - Google Patents

Info

Publication number
JP2021525220A5
JP2021525220A5 JP2020541791A JP2020541791A JP2021525220A5 JP 2021525220 A5 JP2021525220 A5 JP 2021525220A5 JP 2020541791 A JP2020541791 A JP 2020541791A JP 2020541791 A JP2020541791 A JP 2020541791A JP 2021525220 A5 JP2021525220 A5 JP 2021525220A5
Authority
JP
Japan
Prior art keywords
methyl
hydroxy
azaspiro
decane
carbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020541791A
Other languages
English (en)
Japanese (ja)
Other versions
JP7464526B2 (ja
JP2021525220A (ja
Filing date
Publication date
Priority claimed from GBGB1801562.8A external-priority patent/GB201801562D0/en
Application filed filed Critical
Publication of JP2021525220A publication Critical patent/JP2021525220A/ja
Publication of JP2021525220A5 publication Critical patent/JP2021525220A5/ja
Application granted granted Critical
Publication of JP7464526B2 publication Critical patent/JP7464526B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020541791A 2018-01-31 2019-01-31 4-ヒドロキシピペリジン誘導体およびユビキチン特異的プロテアーゼ19(usp19)の阻害剤としてのその使用 Active JP7464526B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1801562.8A GB201801562D0 (en) 2018-01-31 2018-01-31 Pharmaceutical compounds
GB1801562.8 2018-01-31
PCT/GB2019/050271 WO2019150119A1 (en) 2018-01-31 2019-01-31 4-hydroxypiperidine derivatives and their use as inhibitors of ubiquitin specific protease 19 (usp19)

Publications (3)

Publication Number Publication Date
JP2021525220A JP2021525220A (ja) 2021-09-24
JP2021525220A5 true JP2021525220A5 (cg-RX-API-DMAC7.html) 2022-02-02
JP7464526B2 JP7464526B2 (ja) 2024-04-09

Family

ID=61558043

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020541791A Active JP7464526B2 (ja) 2018-01-31 2019-01-31 4-ヒドロキシピペリジン誘導体およびユビキチン特異的プロテアーゼ19(usp19)の阻害剤としてのその使用

Country Status (16)

Country Link
US (1) US11807646B2 (cg-RX-API-DMAC7.html)
EP (1) EP3746432B1 (cg-RX-API-DMAC7.html)
JP (1) JP7464526B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200115623A (cg-RX-API-DMAC7.html)
CN (1) CN112135818A (cg-RX-API-DMAC7.html)
AU (1) AU2019213562A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020015449A2 (cg-RX-API-DMAC7.html)
CA (1) CA3089538A1 (cg-RX-API-DMAC7.html)
ES (1) ES2934958T3 (cg-RX-API-DMAC7.html)
GB (1) GB201801562D0 (cg-RX-API-DMAC7.html)
IL (1) IL276324A (cg-RX-API-DMAC7.html)
MX (1) MX2020008091A (cg-RX-API-DMAC7.html)
RU (1) RU2020127848A (cg-RX-API-DMAC7.html)
SG (1) SG11202007179SA (cg-RX-API-DMAC7.html)
WO (1) WO2019150119A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202004909B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220033397A1 (en) * 2018-12-06 2022-02-03 Almac Discovery Limited Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)
JP2022510700A (ja) * 2018-12-06 2022-01-27 アルマック・ディスカバリー・リミテッド 治療において使用するusp19阻害剤
CA3134564A1 (en) * 2019-05-06 2020-11-12 Lawrence Marcin Inhibiting usp19
GB202104097D0 (en) * 2021-03-24 2021-05-05 Almac Discovery Ltd Pharmaceutical compounds
GB202311227D0 (en) 2023-07-21 2023-09-06 Almac Discovery Ltd Pharmaceutical compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO111096A0 (en) * 1996-07-18 1996-08-08 Fujisawa Pharmaceutical Co., Ltd. New compound
US7217710B2 (en) 2001-10-02 2007-05-15 Smithkline Beecham Corporation Substituted pyrazolopyrimidines
FR2873691B1 (fr) 2004-07-29 2006-10-06 Sanofi Synthelabo Derives d'amino-piperidine, leur preparation et leur application en therapeutique
EP2565186A1 (en) * 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
MA41291A (fr) * 2014-12-30 2017-11-07 Forma Therapeutics Inc Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
HK1248221A1 (zh) * 2015-02-05 2018-10-12 Forma Therapeutics, Inc. 异噻唑啉酮类,吡唑并嘧啶酮类和吡咯并嘧啶酮作为泛蛋白特异性蛋白酶7抑制剂
EP3253765A1 (en) * 2015-02-05 2017-12-13 Forma Therapeutics, Inc. Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors
EP3253738A1 (en) * 2015-02-05 2017-12-13 Forma Therapeutics, Inc. Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
PL3468971T3 (pl) * 2016-06-10 2020-08-10 Les Laboratoires Servier Nowe pochodne (hetero)arylo-piperydynylowe, sposoby ich wytwarzania oraz zawierające je kompozycje
FR3052452B1 (fr) * 2016-06-10 2018-06-22 Les Laboratoires Servier Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB201612938D0 (en) * 2016-07-26 2016-09-07 Almac Discovery Ltd Pharmaceutical compounds
GB201617758D0 (en) * 2016-10-20 2016-12-07 Almac Discovery Limited Pharmaceutical compounds
US20220033397A1 (en) * 2018-12-06 2022-02-03 Almac Discovery Limited Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)

Similar Documents

Publication Publication Date Title
EP4598915A2 (en) Tethered heterocyclic inhibitors of kras g12c mutant proteins and uses thereof
US10934302B1 (en) SHP2 phosphatase inhibitors and methods of use thereof
TWI762939B (zh) Btk抑制劑環衍生物及其製備方法和藥學上的應用
RU2020127848A (ru) Производные 4-гидроксипиперидина и их применение в качестве ингибиторов убиквитин-специфической протеазы 19 (usp19)
JP2024502433A5 (cg-RX-API-DMAC7.html)
KR101812357B1 (ko) Cdk4/6의 억제제로서의 피롤로피리미딘 화합물
JP2022543689A (ja) Shp2阻害剤
KR102003532B1 (ko) 새로운 (헤테로)아릴-치환된-피페리디닐 유도체, 이의 제조를 위한 방법 및 이를 함유하는 약학적 조성물
JP2016525092A5 (cg-RX-API-DMAC7.html)
JP2019535664A5 (cg-RX-API-DMAC7.html)
JP2022504936A5 (cg-RX-API-DMAC7.html)
AU2019216728A1 (en) Heteroaryl pyridone and aza-pyridone compounds as inhibitors of Btk activity
JP2014506929A5 (cg-RX-API-DMAC7.html)
RU2019115115A (ru) Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7
JP2021504380A5 (cg-RX-API-DMAC7.html)
JP2014525397A (ja) 3環性ヘテロ環化合物及びjak阻害剤
AU2024332123A1 (en) Compositions comprising werner syndrome helicase inhibitors and methods of using the same
JP2017518326A5 (cg-RX-API-DMAC7.html)
JP2025538097A (ja) がんを処置するための方法
CA2687035A1 (en) Amino-heterocyclic compounds
JP2022512128A5 (cg-RX-API-DMAC7.html)
HRP20160649T1 (hr) Novi derivati tienopirimidina, postupci za njihovo pripremanje i njihova terapeutska uporaba
WO2025217247A1 (en) Tethered spiro-heterocyclic inhibitors of kras g12c mutant proteins and uses thereof
WO2025230878A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
JP2021527099A (ja) Gaba a alpha5 pamとしての新規イソオキサゾリルエーテル誘導体